Sastasundar Ventures Limited — Important, 14-11-2024: Financial Result Updates

Sastasundar Ventures Limited has announced a board meeting to review its financial results for the quarter and half-year ended September 30, 2024. The consolidated financial results indicate that the company generated total revenue of ₹273.53 crore, showing a decline from the previous year’s figure of ₹358.49 crore, reflecting a revenue drop of approximately 23.6%. This decrease can potentially be attributed to challenges in demand within the healthcare network and increased competition.

The net loss for the half-year is reported at ₹148.98 crore, compared to a net profit of ₹29.66 crore for the same period last year, leading to an EPS of ₹-34.40. Factors affecting profitability include significant operational costs related to finance expenses and the restart of impaired assets, which collectively hindered earnings.

Operational costs rose by 34.5% due to continued investment in expansion, impacting cost efficiency. The balance sheet displays healthy liquidity with cash and cash equivalents at ₹250.07 crore, slightly down from ₹336.08 crore at the beginning of the period, while total assets stood at ₹1004.74 crore.

Strategically, the company is focusing on streamlining operations and strengthening its market position, particularly in the healthcare sector where it has recently made significant investments. Given the current financial performance and strategic initiatives, a "hold" stance may be warranted for retail investors while assessing the recovery trajectory in subsequent quarters.